Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Rahul Aggarwal

Boston (United States of America)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Professor G. Lip (Liverpool, GB)

Presentation thumbnail

Repeated measurement of the novel atrial biomarker BMP10 improves risk stratification in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial

Doctor K. Gkarmiris (Uppsala, SE)

Abstract Slides Video

Presentation thumbnail

Differences in causality between exposures and stroke subtypes: a mendelian randomisation approach

Associate Professor G. Klappacher (Vienna, AT)

Abstract Slides Video

Presentation thumbnail

Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

Doctor M. Anjum (Baerum, NO)

Abstract Slides Video

Access the full session

Session thumbnail

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

The usefulness of the direct oral anticoagulant score for predicting bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: a multicenter study.

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Presentation

Predicting bleeding risk in frail older patients with atrial fibrillation using data from the FRAIL-AF trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources